We have evaluated the ability of bioballistic "gene gun" immunization of mi
ce with plasmid DNA encoding clinically relevant tumor antigens to induce p
rotective antitumor immunity. Mice immunized with plasmid cDNA encoding the
cervical carcinoma-associated human papillomavirus 16-E7 gene product exhi
bited potent anti-E7-specific cytotoxic T lymphocytes and were protected co
mpletely against a subsequent challenge with the E7(+) C3 sarcoma. Of perha
ps greater clinical interest, genetic immunization using cDNA encoding the
normal, germline-encoded murine melanosomal protein tyrosinase-related prot
ein-2 (TRP-2) resulted in delayed outgrowth of TRP-2(+) B16 melanoma in mic
e and was associated with an in vivo activation of TRP-2-specific cytotoxic
T lymphocytes. Codelivery of plasmid cDNA encoding TRP-2 and the T helper
1-biasing cytokine murine interleukin-12 considerably enhanced the antitumo
r efficacy of these gene-based melanoma vaccines.